• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

R3327-G大鼠前列腺肿瘤中雄激素不敏感细胞的体内选择:己烯雌酚二磷酸治疗与睾丸切除术的比较

In vivo selection of androgen-insensitive cells in R3327-G rat prostate tumors: diethylstilbestrol diphosphate treatment versus orchiectomy.

作者信息

Pollack A, Block N L, Stover B J, Irvin G L, Fuentes M P, Claflin A J, Malinin T I

出版信息

J Natl Cancer Inst. 1983 May;70(5):907-14.

PMID:6573535
Abstract

Tumors grown in diethylstilbestrol diphosphate (DES)-treated rats grew significantly more slowly than tumors grown in orchiectomized animals, and tumors grown in orchiectomized animals grew significantly more slowly than tumors grown in controls (intact male rats). When these tumors (phase I) were dispersed and reimplanted into DES-treated, orchiectomized, or control rats in all possible combinations (phase II), a partial selection of androgen-insensitive cells was observed in tumors grown in DES-treated animals. Tumors grown in DES-treated phase I animals responded significantly less to DES treatment or orchiectomy in phase II. In contrast, tumors from phase I orchiectomized animals showed the same responses to orchiectomy in phase II. Since the administration of exogenous testosterone propionate prevented the growth rate inhibitory effects of both DES treatment and orchiectomy, the added effect of DES seemed to be antiandrogenic.

摘要

在己烯雌酚二磷酸酯(DES)处理的大鼠体内生长的肿瘤,其生长速度明显慢于在去势动物体内生长的肿瘤,而去势动物体内生长的肿瘤,其生长速度又明显慢于对照组(完整雄性大鼠)体内生长的肿瘤。当这些肿瘤(第一阶段)被分散并以所有可能的组合方式重新植入经DES处理、去势或对照大鼠体内(第二阶段)时,在经DES处理的动物体内生长的肿瘤中观察到了部分雄激素不敏感细胞的选择。在第一阶段经DES处理的动物体内生长的肿瘤,在第二阶段对DES处理或去势的反应明显较小。相比之下,第一阶段去势动物的肿瘤在第二阶段对去势表现出相同的反应。由于给予外源性丙酸睾酮可阻止DES处理和去势对生长速度的抑制作用,DES的附加作用似乎是抗雄激素的。

相似文献

1
In vivo selection of androgen-insensitive cells in R3327-G rat prostate tumors: diethylstilbestrol diphosphate treatment versus orchiectomy.R3327-G大鼠前列腺肿瘤中雄激素不敏感细胞的体内选择:己烯雌酚二磷酸治疗与睾丸切除术的比较
J Natl Cancer Inst. 1983 May;70(5):907-14.
2
Flow cytometric analysis of the response of the R3327-G rat prostatic adenocarcinoma to endocrine manipulation.R3327-G大鼠前列腺腺癌对内分泌调控反应的流式细胞术分析
J Surg Oncol. 1981;18(4):389-98. doi: 10.1002/jso.2930180408.
3
Sustained in vivo regression of Dunning H rat prostate cancers treated with combinations of androgen ablation and Trk tyrosine kinase inhibitors, CEP-751 (KT-6587) or CEP-701 (KT-5555).用雄激素去除与Trk酪氨酸激酶抑制剂CEP-751(KT-6587)或CEP-701(KT-5555)联合治疗的Dunning H大鼠前列腺癌在体内持续消退。
Cancer Res. 1999 May 15;59(10):2395-401.
4
Effects of intermittent diethylstilbestrol diphosphate administration on the R3327 rat prostatic carcinoma.间歇性给予己烯雌酚二磷酸酯对R3327大鼠前列腺癌的影响。
Cancer Res. 1987 Nov 15;47(22):5967-70.
5
Tumor progression in serial passages of the Dunning R3327-G rat prostatic adenocarcinoma: growth rate response to endocrine manipulation.
Cancer Res. 1985 Mar;45(3):1052-7.
6
Growth inhibition by diethylstilbestrol and relapse of the Noble rat prostatic tumor.
Hinyokika Kiyo. 1988 Jan;34(1):107-15.
7
Castration induces apoptosis in the ventral prostate but not in an androgen-sensitive prostatic adenocarcinoma in the rat.去势诱导大鼠腹侧前列腺细胞凋亡,但对雄激素敏感的前列腺腺癌细胞无此作用。
Cancer Res. 1994 Jul 1;54(13):3594-601.
8
Hormone sensitivity of the R3327-G rat prostate adenocarcinoma: growth rate, DNA content, and hormone receptors.R3327-G大鼠前列腺腺癌的激素敏感性:生长速率、DNA含量及激素受体
Cancer Res. 1982 Jun;42(6):2184-90.
9
Quiescence in R3327-G rat prostate tumors after androgen ablation.雄激素去除后R3327-G大鼠前列腺肿瘤的静止状态。
Cancer Res. 1997 Jun 15;57(12):2493-500.
10
Subcellular distribution in vivo of testosterone and salt extractability of nuclear androgen complexes in the prostate and prostatic adenocarcinoma: effect of estrogen treatment.睾酮在体内的亚细胞分布以及前列腺和前列腺腺癌中核雄激素复合物的盐提取性:雌激素治疗的影响。
In Vivo. 1992 Nov-Dec;6(6):573-8.

引用本文的文献

1
A tissue biomarker-based model that identifies patients with a high risk of distant metastasis and differential survival by length of androgen deprivation therapy in RTOG protocol 92-02.一种基于组织生物标志物的模型,该模型通过放射治疗肿瘤学组(RTOG)92-02方案中雄激素剥夺治疗的时长来识别远处转移风险高和生存存在差异的患者。
Clin Cancer Res. 2014 Dec 15;20(24):6379-88. doi: 10.1158/1078-0432.CCR-14-0075. Epub 2014 Oct 7.
2
Antisense MDM2 enhances the response of androgen insensitive human prostate cancer cells to androgen deprivation in vitro and in vivo.反义MDM2增强雄激素不敏感型人前列腺癌细胞在体外和体内对雄激素剥夺的反应。
Prostate. 2008 May 1;68(6):599-609. doi: 10.1002/pros.20731.
3
Studies on the mammary tumor-inhibiting effects of diethylstilbestrol and its mono- and diphosphate.
己烯雌酚及其单磷酸酯和双磷酸酯的乳腺肿瘤抑制作用研究
J Cancer Res Clin Oncol. 1986;111(2):110-4. doi: 10.1007/BF00400747.
4
The tumor-inhibiting effect of diethylstilbestrol and its diphosphate on the Nb-H and Nb-R prostatic carcinomas of the rat.己烯雌酚及其二磷酸盐对大鼠Nb - H和Nb - R前列腺癌的抑瘤作用。
J Cancer Res Clin Oncol. 1990;116(2):159-67. doi: 10.1007/BF01612671.